Metastatic Lung Adenocarcinomas (DBCOND0084520)

Identifiers

Synonyms

Lung adenocarcinoma metastatic / Metastatic Lung Adenocarcinoma / Lung adenocarcinoma stage IV / Adenocarcinoma of lung, stage IV (finding) / Adenocarcinoma lung stage IV / Adenocarcinoma of lung stage IV / Adenocarcinoma of Lung / Lung adenocarcinoma NOS / Lung adenocarcinoma / Adenocarcinoma lung / Adenocarcinoma of lung (disorder)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02891733	Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas	No drug interventions	Not Available	Not Available	withdrawn
NCT02946359	A+C in Metastatic Lung Adenocarcinoma Cancer	Bevacizumab Crizotinib	treatment	2	unknown_status
NCT03044626	Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC	Nivolumab	treatment	2	completed
NCT03345810	Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)	Carboplatin Durvalumab Gemcitabine Paclitaxel Vinorelbine	treatment	2	completed
NCT02975752	EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA	No drug interventions	Not Available	Not Available	completed
NCT04533451	Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer	Carboplatin Pembrolizumab Pemetrexed	treatment	2	active_not_recruiting
NCT05733000	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	Devimistat Fluorouracil Gemcitabine Hydroxychloroquine Lipoic acid	treatment	2	recruiting